Clinical trials
Phase 2 Bone Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Brown University | 2 |
| Actuate Therapeutics Inc. | 1 |
| AstraZeneca | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emerald Clinical Inc. | 1 |
| Hackensack Meridian Health | 1 |
| Heike E Daldrup-Link | 1 |
| Infinity Pharmaceuticals, Inc. | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Neoplasms | 24 |
| Sarcoma | 14 |
| Osteosarcoma | 9 |
| Histiocytoma, Malignant Fibrous | 5 |
| Rhabdomyosarcoma | 5 |
| Leiomyosarcoma | 4 |
| Liposarcoma | 4 |
| Neoplasm Metastasis | 4 |
| Sarcoma, Ewing | 4 |
| Sarcoma, Synovial | 4 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.